HAVING painstakingly worked on the production, renowned filmmaker and CEO of Mainframe Productions Tunde Kelani recently premiered his latest film, Dazzling Mirage.
Held at the MUSON Centre, Onikan, Lagos, the first public screening, which opened with a special red carpet reception, brought together cast and crew of the production, notable celebrities and stakeholder in the entertainment industry, who had the opportunity of being among the first set of Nigerians to see the movie.
Produced in partnership with Lagos State Government, Still Earth Limited, Access Bank and other key sponsors, the advocacy film aims at creating awareness on the medical disorder known as Sickle Cell, advocating against stigmatisation, as well as help people make better informed decisions.
Dazzling Mirage is an inspiring story of a young advertising executive, a talented beautiful lady living with sickle cell disorder. Funmiwo (played by Kemi ‘Lala’ Akindoju) overcomes social stigma, prejudice and her own low self esteem to achieve career success, marriage and motherhood.
“Sickle cell disease is a genetic disorder primarily affecting people of African ancestry. The disease causes the body to make abnormal sickle or crescent-shaped red blood cells that can block vessels, causing organ damage and pain,” Tunde Kelani said.
The flick is adapted from a novel of the same title by Yinka Egbokhare, while the screenplay was by acclaimed writer and playwright, Ade Solanke. The film is a story of love, denial, pain, and perseverance.
According to the producers, Dazzling Mirage is proudly Nigerian, with all the scenes shot in different locations in the country. The seamless transition in the film directed and produced by the veteran filmmaker, is an attestation to an adequate deployment of human and material resources and the improved production capacity of film producers in Nigeria.
The movie parades some of the best in Nollywood such as Kemi ‘Lala’ Akindoju, Kunle Afolayan, Taiwo Ajai-Lycett, Bimbo Manuel, Carol King, Yomi Fash Lanso, Seun Akindele and others.